While some of the details of resuscitation of the bleeding patient remain contentious, the basic principles are clear. Adequate resuscitation imPlies the prompt restoration of tissue oxygenation by achievement and maintenance of airway patency, adequate ventilation, cardiac rhythm and intravascular volume. The choice of fluid for primary resuscitation is considerably less important than the care with which it ought to be administered. The volume of fluid required for primary resuscitation varies and there is no well-defined endpoint against which to titrate fluid resuscitation. However, as the complications and mortality of shock are related to the degree and the duration of shock, definitive (usually surgical) intervention should be undertaken early if the clinical features of shock cannot be readily reversed or if the maintenance of clinically adequate perfusion cannot be achieved with the administration of less than 200 ml of fluid per hour.
Resuscitation of the patient with acute haemorrhage requires the prompt restoration of adequate tissue oxygenation and rapid control of bleeding. There are three important aspects in the management of such patients; diagnosis of the site and severity of the haemorrhage and of associated injuries and illness, resuscitation and definitive management. The relative importance of these three aspects of management depends on the clinical situation, particularly the site and severity of the haemorrhage. Often these three aspects of care need to proceed simultaneously.
SEVERITY OF HAEMORRHAGE The clinical assessment of haemorrhage is discussed elsewhere.! A loss of 20-30070 of blood volume is associated with organ damage and 50% blood loss is associated with a high mortality rate. 2 As well as the magnitude of blood loss, the rate of haemorrhage is an important determinant of the capacity of defence mechanisms to maintain pressure and tF.R.A.C.P., Senior Medical Registrar and Fellow in Intensive Care. *F.F.A.R.A.C.S., Head, Intensive Therapy Unit. Address for Reprints: Dr. M. Fisher, F.R.A.R.A.C.S., Head, Intensive Therapy Unit, Royal North Shore Hospital, S1. Leonards, N.S.W. 2065, Australia.
flow. Rapidly exsanguinating haemorrhage demands early definitive management to prevent organ damage and minimise mortality, whereas slower rates of bleeding allow more detailed investigation prior to definitive control. With cardiac arrest due to haemorrhage, some authors believe that the only possible effective therapy is immediate thoracotomy, internal cardiac massage and compression of the descending aorta 3 while others recommend fluid resuscitation and inotropic support. 2 A recent study has suggested that thoracotomy is of little benefit in the management of asystolic patients with haemorrhage except in those with penetrating chest wounds. 4 SITE OF HAEMORRHAGE The effect of the site of haemorrhage on priorities in management are obvious. Where the site leads to high-pressure effects (intracranial and intrapericardial), definitive procedures assume the highest priority. Where haemorrhage can be locally controlled with pressure (e.g. limbs) restoration of blood volume and organ per fusion should take priority over surgical management. Where such Anaesthesia and Il1Iensive Car/!, Vul. 12, No. 3, Augusf, 1984 control is not possible (e.g. ruptured aortic aneurysm) surgical management has the highest priority and transfusion merely bridges the gap between diagnosis and operation. With gastrointestinal haemorrhage, precise diagnosis is important as the therapeutic options are so varied. In this situation, unless the source of the haemorrhage is clinically apparent or the rate of haemorrhage immediately life-threatening, diagnostic procedures (e.g. endoscopy, mesenteric angiography) assume a higher priority and may be coupled with definitive control (e.g. diathermy, sclerosis or embolisation) .
CO-EXISTENT DISEASE
The presence of co-existent pathology may alter the priorities of management in two ways: 1. Co-existent disease may contribute directly to haemorrhage (e.g. haemophilia, hepatic failure) or may have precipitated trauma (e.g. hypoglycaemia, arrhythmia, epilepsy) and in both situations the underlying condition may need to be treated as part of the resuscitative effort. 2. Co-existent disease (e.g. cardiac disease, beta-blockade, renal disease, anaemia, etc.) may alter the physiological response to and clinical signs of haemorrhage and so the ability to tolerate hypovolaemia or inappropriate resuscitation. MANAGEMENT Initial attention must be paid to the patency of the airway, and the adequacy of ventilation and of cardiac rhythm. While a high concentration of oxygen should be administered, it is of little benefit if the cardiac output is low as the pulmonary venous admixture is increased and the delivery of oxygen to tissues remains impaired. There is no place for the use of low-concentration oxygen masks in the presence of shock as the elevation of blood oxygen content is of greater importance than the theoretical hazard of depressing ventilation in the patient who may be unresponsive to a raised carbon dioxide level. At the same time as airway patency and ventilation are secured, at least one intravenous cannula should be inserted, an infusion commenced and direct control of haemorrhage attempted.
DIRECT CONTROL OF HAEMORRHAGE Direct pressure may control external haemorrhage and is preferable to the use of external tourniquets. Medical Antishock Trousers (MAST suit) may be useful in the control of abdominal or pelvic bleeding as well, and if successful in control of haemorrhage should not be removed until volume restoration has been achieved, other more urgent problems dealt with and preparation made for definitive (usually surgical) control should this be required. Premature deflation may be associated with catastrophic haemorrhage and shock. 5 VOLUME LOADING Fluid should be infused rapidly at first to restore intravascular volume to safe levels and then more slowly to achieve a normal blood volume and normal total body water. If a stable circulation cannot be achieved with one litre of colloid or three litres of crystalloid solution, or if a stable circulation cannot subsequently be maintained with less than 200 ml of fluid per hour, then surgery assumes a high priority. If such is not the case, then accurate diagnosis may be sought and therapeutic options other than surgery considered.
DIAGNOSIS
Where the rate and site of haemorrhage allow, a number of diagnostic issues need to be addressed. I. What co-existent disease states may have contributed to either the initial precipitating event or to the ongoing haemorrhage? 2. What co-existent disease states are present and need to be considered in the formulation of treatment plans? 3. What other injuries has the patient sustained and what is their priority of management (e.g. pneumothorax, fractured bones, head injury, myocardial contusion ... )? 4. What is the precise site of the haemorrhage and how can definitive control best be achieved?
CRYSTALLOID vs COLLOID Few issues in resuscitation have created as much controversy or as much polarisation of opinion as the relative benefits of the available resuscitative fluids in the shocked patient. Numerous studies have purported to show that either crystalloid or colloid solutions are superior in this situation. To the humble clinician who finds that, in practice, most patients can be successfully resuscitated with either solution, these results are confusing. In reviews of the subject, Col 6 and Poole et al. 7 have pointed out that most studies have been deficient in some areas. The deficiencies have been in the choice of model or the choice of endpoint. The relevance of animal models has not been established, and in human studies the severity of haemorrhage and the presence or absence of shock has been variable. Many of the studies have involved resuscitation based on a formula or on right atrial pressure rather than a more clinically applicable endpoint such as cardiac output. Furthermore, restoration to "normal" cardiac output or wedge pressure may not be a suitable endpoint for resuscitation nor a reliable predictor of survival. 8 The adequacy of resuscitation in many studies has not been established 9 -12 and fluid overload has been a major factor in others. 13-15 Several observations may, however, be inferred from the multitude of published studies: 1. Blood transfusion remains the most significant advance in the management of haemorrhagic shock.
Haemodilution prior to transfusion carries
theoretical benefits in the restoration of capillary blood -flow, with some experimental support. 16-18 3. Anaemia is better tolerated than hypovolaemia. 4. Greater quantities of crystalloid than colloid are required to achieve restoration of blood volume and a given level of haemodilution. 9 ,1I-14 5. Crystalloids are cheaper than colloids. 6. Neither colloids nor crystalloids significantly impair coagulation in usual therapeutic doses. 7. There is no conclusive evidence that the administration of any particular fluid, apart from blood, confers on the bleeding patient significant differential benefit in terms of morbidity or mortality when fluid overload is excluded. 8. The continuing controversy, in spite of decades of experience, several major wars, and the sacrifice of innumerable experimental animals, suggests that any difference that may emerge in the future between crystalloid and colloid resuscitation in haemorrhagic shock will be small. The crystalloid vs colloid controversy may well be an example of the "toss-up" situation 19 where neither option can be scientifically demonstrated to affect outcome, and the vehemence of the proponents of the various options seems inversely proportional to the scientific support for their proposals.
WHICH COLLOID?
No particular colloid has been shown to have any clearcut advantage over the others. All commercially available colloid solutions are associated with a low incidence of anaphylactoid reactions,20 usually not of clinical significance, and rarely described in the shocked patient. The major differences between colloid solutions are half-life and volume of distribution. These differences have not been shown to be advantageous or disadvantageous, merely differences. Low molecular weight dextrans have proposed rheological advantages 21 ,22 although their benefit in respect of tissue oxygen delivery may only reflect their haematocrit and viscositylowering properties. 23
BLOOD AND BLOOD PRODUCTS Where initial resuscitation is adequate, control of haemorrhage rapid and effective, and massive transfusion thus not required, the efficacy of blood transfusion and the role of the blood delivery service are justifiably taken for granted: However, where there is continuing major haemorrhage and where adequate control of haemorrhage is delayed or difficult, the haematologist and the blood transfusion service assume a new pre-eminence. The potential problems of massive transfusion are well known and their prevention and management require a co-ordinated approach involving the entire health team. Moderate haemorrhage may be adequately managed with the administration of stored blood and blood products in conjunction with adequate haemostasis. Group-specific, uncrossmatched blood, with its inherent serological safetY,24,25 should be available in most centres within minutes. Massive haemorrhage, however, may tax the resources of even the best organised blood delivery service and the haemostatic and Anaesthesia and Intensive Care, Vol. 12, No. 3, August, 1984 oxygen transport deficiencies of stored blood may become apparent. In this situation, the administration of group-specific fresh donor blood may be life-saving. While the organisation of such a system within a hospital framework may be very difficult, the results are often dramatic.
OTHER PROBLEMS IN RESUSCITATION

Acute renal failure
Acute renal failure (ARF), in association with trauma, is associated with significant mortality. While this, in part at least, reflects the severity of the initial insult rather than the renal failure itself, renal failure is associated with a number of specific problems including increased susceptibility to infection, increased incidence of gastrointestinal haemorrhage and a bleeding diathesis. 26 The most important factor in the prevention of ARF is the prompt restoration of renal blood flow. While diuretics exhibit a protective role in experimental animals,27-29 their role in man, when instituted by necessity after the event, is not well established. The use of mannitol and urinary alkalinisation in the protection of kidneys from the nephrotoxic effect of myoglobin in crush injuries has become commonplace, although their benefit, too, has yet to be objectively established. Dopamine may improve urine output and creatinine clearance in man 30 ,3t and with frusemide has a protective role against acute renal failure in a canine model. 26 Again, it does not have an established role in the prevention of renal failure in man. Diuretic therapy in acute renal failure promotes a significantly earlier diuresis,32,33 which at least makes it easier to manage the patient, and has a proposed role in the conversion of oliguric to non-oliguric renal failure with its attendant better prognosis. 34
ACUTE RESPIRATORY FAILURE
Much has been written of the pathogenesis of the syndrome of post-haemorrhagic pulmonary insufficiency. There is no doubt that overtransfusion, particularly with colloidal solutions, prolongs the period of obligatory respiratory support,'S No study, however, has yet shown that the incidence or severity of this disorder can be influenced by the selection of a particular resuscitative fluid nor by the administration of corticosteroids or other Anaesthesia and Intensive Core, Vol. 12, No. 3, August, 1984 agents. Early intermittent mandatory ventilation with PEEP may ameliorate the course of post-traumatic AEDS 35 but has no established role in its prevt::ntion. Clearer definition of this disorder is needed together with agreement on diagnostic criteria identifiable early in the course of the disease. This may allow more detailed analysis of the effects of therapeutic intervention on the development and outcome of this process.
